| 注册
首页|期刊导航|中国药理学与毒理学杂志|胰高血糖素样肽1受体激动剂在药物成瘾中的作用研究进展

胰高血糖素样肽1受体激动剂在药物成瘾中的作用研究进展

卢关伊 邓青梅 吴宁 李锦

中国药理学与毒理学杂志2024,Vol.38Issue(11):846-858,13.
中国药理学与毒理学杂志2024,Vol.38Issue(11):846-858,13.DOI:10.3867/j.issn.1000-3002.2024.11.006

胰高血糖素样肽1受体激动剂在药物成瘾中的作用研究进展

Research advance in roles of glucagon-like peptide-1 receptor agonists in drug addiction

卢关伊 1邓青梅 1吴宁 1李锦1

作者信息

  • 1. 军事医学研究院国家安全特需药品全国重点实验室,神经精神药理学北京市重点实验室,北京 100850
  • 折叠

摘要

Abstract

Drug addiction is a major medical and social issue globally,but there is still a lack of ideal clinical treatments.Glucagon-like peptide-1(GLP-1),a key gut-brain peptide,and its receptor agonists have been approved for the treatment of type 2 diabetes and obesity.In recent years,the role of GLP-1 receptor agonists in combating drug addiction has received increasing attention.Based on an overview of the GLP-1 system and its receptor agonist,this article reviews the role of GLP-1 receptor agonists in drug addiction at both the nonclinical and clinical levels by focusing on addictive psychoactive substances(including alcohol,tobacco,cocaine,opioids,and amphetamines).Future developments are also predicted to provide new clues to the mechanism of drug addiction and development of therapeutic drugs.

关键词

胰高血糖素样肽1/胰高血糖素样肽1受体激动剂/药物成瘾

Key words

glucagon-like peptide-1/glucagon-like peptide-1 receptor agonists/drug addiction

分类

医药卫生

引用本文复制引用

卢关伊,邓青梅,吴宁,李锦..胰高血糖素样肽1受体激动剂在药物成瘾中的作用研究进展[J].中国药理学与毒理学杂志,2024,38(11):846-858,13.

基金项目

国家重点研发计划(2023YFC3304201) (2023YFC3304201)

国家自然科学基金(82373853) (82373853)

国家自然科学基金(81973303) National Key Research and Development Program(2023YFC3304201) (81973303)

National Natural Science Foundation of China(82373853) (82373853)

and National Natural Science Foundation of China(81973303) (81973303)

中国药理学与毒理学杂志

OA北大核心CSTPCD

1000-3002

访问量6
|
下载量0
段落导航相关论文